Nurse Pretti, 37, spent his workdays as an intensive care unit nurse at the Department of Veterans Affairs in Minneapolis. He was protesting the presence of ICE agents, who have become an ominous ...

In this study, researchers matched patients using GLP-1RA therapy to those using aspirin to compare colorectal cancer incidence in each population.

Using PROTECT trial data, investigators assessed the possible benefit of early treatment vs active monitoring for cribriform-positive prostate cancer.

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.

Improvement seen in quality of life and reduction in specific symptoms for adolescent and young adult breast cancer survivors.

Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.

Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Gathering first-degree family histories for patients with childhood cancers through currently available questions and a personal history is sufficient to ...

Investigators compared the risk of cancer onset in patients with lupus nephritis treated with calcineurin inhibitors vs ...

A randomized trial found music therapy was noninferior to cognitive behavioral therapy for anxiety in patients with cancer.

Diagnostic evaluation should follow principle of 'as low as reasonably achievable'; systemic therapy should be deferred until second trimester.

In this study from ASCO GI 2026, researchers presented a 4-year follow-up of the phase 3 CheckMate 9DW trial of nivolumab plus ipilimumab in treatment-naïve HCC.